Iclusig 15 mg
Iclusig 15 mg is a medicine authorised by Swissmedic under authorisation number 63097. The authorisation holder is Incyte Biosciences International Sàrl. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 12 February 2014 and the authorisation is valid without a time limit. ATC code L01EA05 places the medicine in the group Antineoplastic agents.
| Authorisation number | 63097 |
|---|---|
| Name | Iclusig 15 mg |
| Full name | Iclusig 15 mg, comprimés pelliculés |
| Authorisation holder | Incyte Biosciences International Sàrl |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EA05 |
| First authorisation | 12 February 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Iclusig 15 mg, comprimés pelliculés | A | 12 February 2014 |
| 2 | Iclusig 45 mg, comprimés pelliculés | A | 12 February 2014 |
| 3 | Iclusig 30 mg, comprimés pelliculés | A | 01 September 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | L01EA05 | 07.16.1. | A |
| 3 | 180 | Tablette(n) | L01EA05 | 07.16.1. | A |
| 5 | 30 | Tablette(n) | L01EA05 | 07.16.1. | A |
| 2 | 30 | Tablette(n) | L01EA05 | 07.16.1. | A |
| 4 | 90 | Tablette(n) | L01EA05 | 07.16.1. | A |
| 6 | 30 | Tablette(n) | L01EA05 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Iclusig 15 mg authorised in Switzerland?
Yes. Iclusig 15 mg is authorised by Swissmedic under authorisation number 63097, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Iclusig 15 mg have?
Iclusig 15 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Iclusig 15 mg?
The authorisation holder is Incyte Biosciences International Sàrl. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.